Jacinto López-Sagaseta

Jacinto López-Sagaseta

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2015 in Computational and Structural Biotechnology Journal
Verified
Journal Article
Open access
JLJacinto López-Sagaseta
Jacinto López-Sagaseta
EMEnrico Malito
Enrico Malito
RRRino Rappuoli
Rino Rappuoli
MBMatthew J. Bottomley
Matthew J. Bottomley
For over 100 years, vaccines have been one of the most effective medical interventions for reducing infectious disease, and are estimated to save millions of lives globally each year. Nevertheless, many diseases are not yet preventable by vaccination. This large unmet medical need demands further research and the development of novel vaccines with high efficacy and safety. Compared to the 19th and early 20th century vaccines that were made of killed, inactivated, or live-attenuated pathogens, modern vaccines containing isolated, highly purified antigenic protein subunits are safer but tend to induce lower levels of protective immunity. One strategy to overcome the latter is to design antigen nanoparticles: assemblies of polypeptides that present multiple copies of subunit antigens in well-ordered arrays with defined orientations that can potentially mimic the repetitiveness, geometry, size, and shape of the natural host-pathogen surface interactions. Such nanoparticles offer a collective strength of multiple binding sites (avidity) and can provide improved antigen stability and immunogenicity. Several exciting advances have emerged lately, including preclinical evidence that this strategy may be applicable for the development of innovative new vaccines, for example, protecting against influenza, human immunodeficiency virus, and respiratory syncytial virus. Here, we provide a concise review of a critical selection of data that demonstrate the potential of this field. In addition, we highlight how the use of self-assembling protein nanoparticles can be effectively combined with the emerging discipline of structural vaccinology for maximum impact in the rational design of vaccine antigens.

1 November 2010 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
NCNoelia Casares
Noelia Casares
FRFrancesc Rudilla
Francesc Rudilla
LALaura Arribillaga
Laura Arribillaga
DLDiana Llopiz
Diana Llopiz
JRJosé-Ignacio Riezu-Boj
José-Ignacio Riezu-Boj
JLJuan José Lasarte
Juan José Lasarte
Immunosuppressive activity of regulatory T cells (Treg) may contribute to the progression of cancer or infectious diseases by preventing the induction of specific immune responses. Using a phage-displayed random peptide library, we identified a 15-mer synthetic peptide, P60, able to bind to forkhead/winged helix transcription factor 3 (FOXP3), a factor required for development and function of Treg. P60 enters the cells, inhibits FOXP3 nuclear translocation, and reduces its ability to suppress the transcription factors NF-κB and NFAT. In vitro, P60 inhibited murine and human-derived Treg and improved effector T cell stimulation. P60 administration to newborn mice induced a lymphoproliferative autoimmune syndrome resembling the reported pathology in scurfy mice lacking functional Foxp3. However, P60 did not cause toxic effects in adult mice and, when given to BALB/c mice immunized with the cytotoxic T cell epitope AH1 from CT26 tumor cells, it induced protection against tumor implantation. Similarly, P60 improved the antiviral efficacy of a recombinant adenovirus expressing NS3 protein from hepatitis C virus. Functional inhibition of Treg by the FOXP3-inhibitory peptide P60 constitutes a strategy to enhance antitumor and antiviral immunotherapies.

23 April 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
JLJacinto López-Sagaseta
Jacinto López-Sagaseta
CDCharles L. Dulberger
Charles L. Dulberger
JCJames E. Crooks
James E. Crooks
CPChelsea D. Parks
Chelsea D. Parks
ALAdrienne M. Luoma
Adrienne M. Luoma
EAErin J. Adams
Erin J. Adams
Significance: Mucosal-associated invariant T (MAIT) cells are a highly conserved lineage of αβ T cells found in most mammals. These cells express a T-cell receptor of low diversity that recognizes vitamin metabolites presented by the MHC-related protein, MR1. Despite the evolutionary divergence of MR1 from other MHC proteins, we have found that MAIT T-cell receptors recognize MR1 using similar molecular strategies as that of the highly diverse, conventional αβ T cells, which recognize classical MHC molecules presenting peptide fragments. Our results also shed light onto how MR1-presented antigens can modulate the MAIT–T-cell receptor affinity and MAIT cell stimulation.

1 March 2009 in Analytical Biochemistry
Verified
Journal Article
Closed access
RRRebecca L. Rich
Rebecca L. Rich
GPGiuseppe A. Papalia
Giuseppe A. Papalia
PFPeter J. Flynn
Peter J. Flynn
JFJamie Furneisen
Jamie Furneisen
JQJohn Quinn
John Quinn
DMDavid G. Myszka
David G. Myszka

4 June 2007 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
JLJacinto López-Sagaseta
Jacinto López-Sagaseta
RMR. Montes
R. Montes
CPC. Puy
C. Puy
NDN. Díez
N. Díez
KFK. Fukudome
K. Fukudome
JHJ. Hermida
J. Hermida

15 November 2013 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
JLJacinto López-Sagaseta
Jacinto López-Sagaseta
CDCharles L. Dulberger
Charles L. Dulberger
AMAmanda McFedries
Amanda McFedries
MCMark Cushman
Mark Cushman
ASAlan Saghatelian
Alan Saghatelian
EAErin J. Adams
Erin J. Adams
MR1-restricted mucosal-associated invariant T (MAIT) cells represent a subpopulation of αβ T cells with innate-like properties and limited TCR diversity. MAIT cells are of interest because of their reactivity against bacterial and yeast species, suggesting that they play a role in defense against pathogenic microbes. Despite the advances in understanding MAIT cell biology, the molecular and structural basis behind their ability to detect MR1–Ag complexes is unclear. In this study, we present our structural and biochemical characterization of MAIT TCR engagement of MR1 presenting an Escherichia coli–derived stimulatory ligand, rRL-6-CH2OH, previously found in Salmonella typhimurium. We show a clear enhancement of MAIT TCR binding to MR1 due to the presentation of this ligand. Our structure of a MAIT TCR/MR1/rRL-6-CH2OH complex shows an evolutionarily conserved binding orientation, with a clear role for both the CDR3α and CDR3β loops in recognizing the rRL-6-CH2OH stimulatory ligand. We also present two additional xenoreactive MAIT TCR/MR1 complexes that recapitulate the docking orientation documented previously, despite having variation in the CDR2β and CDR3β loop sequences. Our data support a model by which MAIT TCRs engage MR1 in a conserved fashion, with their binding affinities modulated by the nature of the MR1-presented Ag or diversity introduced by alternate Vβ usage or CDR3β sequences.